Decoy Therapeutics Inc. · NASDAQ:DCOY
Pierce Frederick II received 33,455 Decoy Therapeutics Inc. shares as an award (Form 4)
Traded Aug 31, 2026 · Filed Sep 2, 2026
On Aug 31, 2026, Pierce Frederick II (Chief Executive Officer) received 33,455 Decoy Therapeutics Inc. shares as an award, leaving 34,844 shares. Filed Sep 2, 2026 (Form 4).
- Awarded
- 33,455 shares
- Holding after
- 34,844 shares
- Trading plan
- No
- Role
- Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | Common Stock | Award | 33,455 | 34,844 | Direct |